Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Agios Pharm (AGIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Agios Pharm's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
34.58 +0.92    +2.73%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
34.58
-0.00
-0.00%
17:17:19 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 694,319
  • Bid/Ask: 33.10 / 36.00
  • Day's Range: 33.16 - 35.36
Agios Pharm 34.58 +0.92 +2.73%

NASDAQ:AGIO Financials

 
A brief overview of the NASDAQ:AGIO financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Agios Pharm over time.

Agios Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 26.82 million compared to USD 14.24 million a year ago. Net loss was USD 352.09 million compared to USD 231.8 million a year ago. Basic loss per share from continuing operations was USD 6.33 compared to USD 4.23 a year ago. Basic loss per share was USD 6.33 compared to USD 4.23 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AGIO Income Statement

Gross margin TTM -1,012.5%
Operating margin TTM -1,459.52%
Net Profit margin TTM -1,312.63%
Return on Investment TTM -32.54%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 7.1 7.4 6.71 5.61
Gross Profit -70.97 -75.08 -63.29 -62.25
Operating Income -106.28 -100.9 -93.7 -90.61
Net Income -95.94 -91.32 -83.81 -81.02

AGIO Balance Sheet

Quick Ratio MRQ 11.47
Current Ratio MRQ 12.27
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 8.88%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 937.12 1007.26 1085.15 1151.3
Total Liabilities 126.1 120.42 120.92 114.77
Total Equity 811.02 886.84 964.24 1036.53

AGIO Cash Flow Statement

Cash Flow/Share TTM -5.3
Revenue/Share TTM 0.48
Operating Cash Flow  -106.67%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -72.49 -61.64 -66.75 -95.18
Cash From Investing Activities 95.51 39.34 47.12 57.6
Cash From Financing Activities 0.847 1.88 0.237 2.47
Net Change in Cash 23.87 -20.42 -19.39 -35.12
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AGIO Comments

Write your thoughts about Agios Pharm
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Jan 31, 2022 5:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is Ready for a good run, bought for $30 , I'm waiting for a run to the north, there are catalysts for the near future, with this breakthrough attempt it can go crazy.
Choong Yen
Choong Yen Jun 14, 2021 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where is everyone?
Zorro Batman
Zorro Batman Dec 08, 2020 10:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's going on?
Cookie Crumbler
Cookie Crumbler May 07, 2020 7:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why my previous note is dated 2016? I posted it in 2020 May...
andrew mccorkle
andrew mccorkle May 07, 2020 7:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
9ok
Jeff Shinn
Alien_Ancestry Oct 10, 2018 12:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Again the hyper-selloff!  Reached a low today of 63.56 (at this point).  Biotech has been on a bull run but now in correction.  Start accumulation...
Joel Hanson
Joel Hanson Dec 16, 2016 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$AGIO Hyper sell off. Get in now. They still have their baby AG-348 which is well tolerated and should succeed with proper regulations.. . Out of 11 analyst, 6 say “buy” 5 say “hold” with an ave 12 month TP of $63.38, a 40.6% ROI.
Cookie Crumbler
Cookie Crumbler Dec 16, 2016 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks Joel - how much did they pay you to say this? see reality is it went from $46.92  to $36.40 - major loss! should, hopefully, and could matters little
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email